Jushi Holdings (JUSHF) Accounts Payables (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Accounts Payables came in at $23.4 million in Q1 2026, up 14.31% year-on-year from $20.5 million in Q1 2025, and up 4.79% on a QoQ basis from $22.3 million in Q4 2025.
Jushi Holdings (JUSHF) Accounts Payables (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Accounts Payables data on file, last reported at $23.4 million in Q1 2026.
- On a quarterly basis, Accounts Payables rose 14.31% year-over-year to $23.4 million in Q1 2026; TTM through Mar 2026 was $23.4 million, a 14.31% increase from a year earlier, with the FY2025 full-year figure at $22.3 million, up 4.06% from the prior year.
- Accounts Payables for Q1 2026 stood at $23.4 million, up from $22.3 million in the prior quarter.
- Over the last five years, Accounts Payables for JUSHF reached as high as $24.9 million in Q1 2023 and fell as low as $14.1 million in Q2 2022.
- Historically, Accounts Payables has averaged $19.6 million across 5 years, with a median of $20.3 million in 2023.
- Across the five-year window, Accounts Payables jumped 102.23% in 2022 and plunged 31.99% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $21.3 million in 2022, then fell by 27.82% to $15.4 million in 2023, then surged by 39.5% to $21.5 million in 2024, then rose by 4.06% to $22.3 million in 2025, then grew by 4.79% to $23.4 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $23.4 million in Q1 2026, $22.3 million in Q4 2025, and $20.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 23.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.40 Mn |
| Dec 31, 2025 | 22.33 Mn |
| Sep 30, 2025 | 20.21 Mn |
| Jun 30, 2025 | 17.38 Mn |
| Mar 31, 2025 | 20.47 Mn |
| Dec 31, 2024 | 21.46 Mn |
| Sep 30, 2024 | 20.11 Mn |
| Jun 30, 2024 | 16.04 Mn |
| Mar 31, 2024 | 16.91 Mn |
| Dec 31, 2023 | 15.38 Mn |
| Sep 30, 2023 | 20.36 Mn |
| Jun 30, 2023 | 21.61 Mn |
| Mar 31, 2023 | 24.87 Mn |
| Dec 31, 2022 | 21.31 Mn |
| Sep 30, 2022 | 18.06 Mn |
| Jun 30, 2022 | 14.05 Mn |
| Dec 31, 2021 | 10.54 Mn |